Sabby Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Sabby Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-673,342	Closed	-$1.28M	–	299
2017 Q1	$1.28M	Sell	673,342 -24,893	-4%	-$48K	0.07%	118
2016 Q4	$1.22M	Buy	698,235 +8,335	+1%	+$17K	0.07%	135
2016 Q3	$1.86M	Sell	689,900 -95,899	-12%	-$244K	0.07%	136
2016 Q2	$1.85M	Buy	785,799 +229,830	+41%	+$634K	0.1%	114
2016 Q1	$1.8M	Sell	555,969 -61,527	-10%	-$227K	0.09%	110
2015 Q4	$2.96M	Buy	617,496 +248,855	+68%	+$1.41M	0.16%	88
2015 Q3	$2.05M	Buy	368,641 +272,541	+284%	+$2.01M	0.08%	153
2015 Q2	$765K	Buy	96,100 +58,800	+158%	+$505K	0.03%	235
2015 Q1	$392K	Buy	+37,300	New	+$510K	0.02%	246

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 42.58% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Sabby Management's BDSI Position: Q2 2017 in Review

Sabby Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2017, closing a stake of 673,342 shares — an estimated $1.28M sold.

Sabby Management first reported a position in BDSI in Q1 2015 and held it in 9 quarters. The position peaked at $2.96M in Q4 2015. 67 funds tracked by Wall St. Rank hold BDSI as of Q2 2017.

Sabby Management reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2017 after selling out during the quarter.
Sabby Management sold 673,342 BioDelivery Sciences International, Inc. shares in Q2 2017, an estimated $1.28M.
Sabby Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2015 and held it in 9 quarters.
Sabby Management's BioDelivery Sciences International, Inc. position peaked at $2.96M in Q4 2015.
67 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2017.

Based on Sabby Management's 13F filing for Q2 2017, filed 14 Aug 2017.